Gilead Sciences names Daniel O’Day chairman and CEODaniel O'Day is leaving Roche to serve as chairman and CEO of Gilead Sciences, effective March 1, 2019. Lupin introduces generic RapafloLupin rolls out generic Rapaflo, which had a market value of about $198.5 million. FDA gives Lupin's generic Eliquis tentative approval The FDA has given tentative clearance for Lupin's generic Eliquis, which had a market value of about $6.4 billion. Innovation's Phil Samples elected to AMSUS board Innovation's Phil Samples has been elected to the board of AMSUS, the Society of Federal Health Professionals. Walgreens unveils Missouri medication disposal kiosks The chain on Tuesday unveiled the first disposal kiosks at one of the 14 locations in the state that house them alongside Missouri Gov. Mike Parson.r Presidential historian Doris Kearns Goodwin to address NACDS Annual Meeting NACDS Annual Meeting attendees will glean insights from renowned presidential historian Doris Kearns Goodwin. HFAP unveils compounding pharmacy certification HFAP's compounding pharmacy certification program ensures high standards of quality. Sun Pharma gets FDA green light for generic Ganirelix The Food and Drug Administration has cleared Sun Pharma's generic Ganirelix, which had a market value of about $67 million, according to IQVIA data. Albertsons bridges pharmacy, store to build health focus Albertsons manages to undertake a big-picture wellness play by bringing together the grocery aisles with its pharmacy offerings. Rite Aid Foundation brings Prescription Drug Safety Initiative to Scranton The Rite Aid Foundation's efforts to help address adolescent drug abuse and misuse will bring the Prescription Drug Safety program to Scranton, Pa.-area high schools. First Previous 552 553 554 555 556 Next Last
